---
title: "TULLMAN STEPHEN A. — Ownership Dossier"
canonical: https://whiteintel.dev/entity/cb912aa2-e506-5d8e-a4b2-067bc6461268
json: https://whiteintel.dev/api/public/dossier/cb912aa2-e506-5d8e-a4b2-067bc6461268
identifier: sec:0001654343
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# TULLMAN STEPHEN A.

**Type:** Company  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001654343`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/cb912aa2-e506-5d8e-a4b2-067bc6461268  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/cb912aa2-e506-5d8e-a4b2-067bc6461268  

## Ownership & control

### Holdings / subsidiaries

- **Aclaris Therapeutics, Inc.** (director) — https://whiteintel.dev/entity/c45df1a6-3c2b-5356-8610-13c79a350a65

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **TULLMAN STEPHEN A.**. Human view: https://whiteintel.dev/entity/cb912aa2-e506-5d8e-a4b2-067bc6461268 · Structured JSON: https://whiteintel.dev/api/public/dossier/cb912aa2-e506-5d8e-a4b2-067bc6461268._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._